Preview

Cancer Urology

Advanced search
Fullscreen

For citations:


Titov K.S., Epifanova M.V., Alimov A.A., Shutov E.V., Nesterova O.Yu., Lebedev S.S., Zapirov G.M. Assessment of kidney injury during immune-targeted therapy (pembrolizumab + axitinib) in patients with metastatic renal cell carcinoma and solitary kidney. Cancer Urology. 2025;21(2):33-41. (In Russ.) https://doi.org/10.17650/1726-9776-2025-21-2-33-41

Views PDF (Rus): 5


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)
X